Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
Amsterdam University Medical Center, University of Amsterdam, Department of Human Genetics, Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands.
Hum Genet. 2024 Aug;143(8):965-978. doi: 10.1007/s00439-024-02688-9. Epub 2024 Jul 19.
ARID1B is the most frequently mutated gene in Coffin-Siris syndrome (CSS). To date, the vast majority of causative variants reported in ARID1B are truncating, leading to nonsense-mediated mRNA decay. In the absence of experimental data, only few ARID1B amino acid substitutions have been classified as pathogenic, mainly based on clinical data and their de novo occurrence, while most others are currently interpreted as variants of unknown significance. The present study substantiates the pathogenesis of ARID1B non-truncating/NMD-escaping variants located in the SMARCA4-interacting EHD2 and DNA-binding ARID domains. Overexpression assays in cell lines revealed that the majority of EHD2 variants lead to protein misfolding and formation of cytoplasmic aggresomes surrounded by vimentin cage-like structures and co-localizing with the microtubule organisation center. ARID domain variants exhibited not only aggresomes, but also nuclear aggregates, demonstrating robust pathological effects. Protein levels were not compromised, as shown by quantitative western blot analysis. In silico structural analysis predicted the exposure of amylogenic segments in both domains due to the nearby variants, likely causing this aggregation. Genome-wide transcriptome and methylation analysis in affected individuals revealed expression and methylome patterns consistent with those of the pathogenic haploinsufficiency ARID1B alterations in CSS cases. These results further support pathogenicity and indicate two approaches for disambiguation of such variants in everyday practice. The few affected individuals harbouring EHD2 non-truncating variants described to date exhibit mild CSS clinical traits. In summary, this study paves the way for the re-evaluation of previously unclear ARID1B non-truncating variants and opens a new era in CSS genetic diagnosis.
ARID1B 是 Coffin-Siris 综合征(CSS)中最常突变的基因。迄今为止,报告的 ARID1B 绝大多数致病变体都是截断的,导致无义介导的 mRNA 衰变。在缺乏实验数据的情况下,只有少数 ARID1B 氨基酸替换被归类为致病性,主要基于临床数据及其从头发生,而大多数其他变体目前被解释为意义不明的变体。本研究证实了位于 SMARCA4 相互作用的 EHD2 和 DNA 结合 ARID 结构域中的非截断/NMD 逃逸的 ARID1B 变体的发病机制。细胞系中的过表达实验表明,大多数 EHD2 变体导致蛋白错误折叠,并形成细胞质聚集物,周围环绕着波形蛋白笼状结构,并与微管组织中心共定位。ARID 结构域变体不仅显示聚集物,而且还显示核聚集物,表现出强大的病理效应。定量 Western blot 分析表明,蛋白水平不受影响。基于附近变体,计算结构分析预测两个结构域中的淀粉样结构域暴露,可能导致这种聚集。受影响个体的全基因组转录组和甲基化分析显示,表达和甲基组模式与 CSS 病例中致病性杂合性缺失的 ARID1B 改变一致。这些结果进一步支持了致病性,并表明了在日常实践中区分此类变体的两种方法。迄今为止,描述的少数携带 EHD2 非截断变体的受影响个体表现出轻微的 CSS 临床特征。总之,这项研究为重新评估以前不清楚的 ARID1B 非截断变体铺平了道路,并开创了 CSS 遗传诊断的新纪元。